Status:
UNKNOWN
Study of Blood Samples in Patients With Breast Cancer
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond...
Detailed Description
OBJECTIVES: * Identify constitutional gene variants associated with a change in response. OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed breast carcinoma
- Received first-line chemotherapy (in neoadjuvant or metastatic setting) comprising anthracyclines and/or taxanes, including for a second primary cancer
- Patient agrees to conservative surgery
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- No contraindication for chemotherapy comprising anthracyclines and/or taxanes
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior adjuvant therapy
Exclusion
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT00959556
Start Date
November 1 2007
Last Update
January 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France, 59020